Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 21, 2011; 17(19): 2450-2453
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2450
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2450
Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib
Giovanni Abbadessa, Lorenza Rimassa, Tiziana Pressiani, Armando Santoro, Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, 20089 Rozzano, Milan, Italy
Giovanni Abbadessa, Department of Human Pathology and Oncology, Program of Genetic Oncology, University of Siena, 53100 Siena, Italy
Cynthia Carrillo-Infante, Department of Human Pathology and Oncology, Program of Molecular Pathology, University of Siena, 53100 Siena, Italy
Emanuele Cucchi, Department of Radiology and Ultrasound, Polidiagnostico CAM, 20052 Monza, Italy
Author contributions: Abbadessa G and Rimassa L designed the paper, performed the acquisition, analysis and interpretation of data, wrote the article and gave final approval; Pressiani T performed the acquisition, analysis and interpretation of data, critically revised the article and gave final approval; Carrillo- Infante C contributed to conception and design of the paper and interpretation of data, wrote the article, and gave final approval; Cucchi E contributed to acquisition, analysis and interpretation of data, critically revised the article, and gave final approval; Santoro A contributed to analysis and interpretation of data, critically revised the article and gave final approval.
Correspondence to: Lorenza Rimassa, MD, Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Via Manzoni 56, 20089 Rozzano, Milan, Italy. lorenza.rimassa@humanitas.it
Telephone: +39-2-82244573 Fax: +39-2-82244590
Received: September 2, 2010
Revised: February 15, 2011
Accepted: February 22, 2011
Published online: May 21, 2011
Revised: February 15, 2011
Accepted: February 22, 2011
Published online: May 21, 2011
Core Tip